Thomas Schreiner

4.0k total citations
84 papers, 2.8k citations indexed

About

Thomas Schreiner is a scholar working on Endocrinology, Diabetes and Metabolism, Social Psychology and Molecular Biology. According to data from OpenAlex, Thomas Schreiner has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Social Psychology and 17 papers in Molecular Biology. Recurrent topics in Thomas Schreiner's work include LGBTQ Health, Identity, and Policy (19 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Thomas Schreiner is often cited by papers focused on LGBTQ Health, Identity, and Policy (19 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Pituitary Gland Disorders and Treatments (12 papers). Thomas Schreiner collaborates with scholars based in Norway, Germany and Belgium. Thomas Schreiner's co-authors include Guy T’Sjoen, Alessandra D. Fisher, Jens Bollerslev, Eva Van Caenegem, Katrien Wierckx, Martin den Heijer, Kaatje Toye, Jean‐Marc Kaufman, Trine Bjøro and Øystein Krüger and has published in prestigious journals such as New England Journal of Medicine, Blood and Endocrine Reviews.

In The Last Decade

Thomas Schreiner

81 papers receiving 2.7k citations

Peers

Countries citing papers authored by Thomas Schreiner

Since Specialization

Citations

This map shows the geographic impact of Thomas Schreiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schreiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schreiner more than expected).

Fields of papers citing papers by Thomas Schreiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schreiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schreiner. The network helps show where Thomas Schreiner may publish in the future.

Co-authorship network of co-authors of Thomas Schreiner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schreiner. A scholar is included among the top collaborators of Thomas Schreiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schreiner. Thomas Schreiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamics of pre-release consumer buzz: Driving communication, search, and participation for market performance 2025 ·Journal of the Academy of Marketing Science ·Thomas Schreiner, Timo Mandler, Harald J. van Heerde, (unknown)	0
2	The role of consumer-based brand equity on the prolongation of trademarks 2024 ·Journal of Brand Management ·(unknown), Thomas Schreiner, Henrik Sattler	2
3	Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence 2020 ·LGBT Health ·Justine Defreyne, (unknown), (unknown), Chantal M Wiepjes, Alessandra D. Fisher, Thomas Schreiner, Martin den Heijer, Jean‐Marc Kaufman, Guy T’Sjoen	14
4	Autoinjector preference among patients with multiple sclerosis: results from a national survey 2017 ·Patient Preference and Adherence ·Volker Limmroth, Joachim Reischl, Bhupinder Mann, (unknown), (unknown), (unknown), Thomas Schreiner	9
5	Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study 2017 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Maartje Klaver, Chantal M Wiepjes, Nienke M. Nota, Annemieke C. Heijboer, Alessandra D. Fisher, Thomas Schreiner, Guy T’Sjoen, Martin den Heijer	70
6	Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study 2017 ·Journal of Bone and Mineral Research ·Chantal M Wiepjes, Mariska Vlot, Maartje Klaver, Nienke M. Nota, (unknown), Renate T. de Jongh, Paul Lips, Annemieke C. Heijboer, Alessandra D. Fisher, Thomas Schreiner, Guy T’Sjoen, Martin den Heijer	57
7	Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion 2015 ·Medical Physics ·H. Fuchs, M. Alber, Thomas Schreiner, Dietmar Georg	15
8	Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case–controlled study (ENIGI) 2014 ·European Journal of Endocrinology ·Eva Van Caenegem, Katrien Wierckx, Youri Taes, Thomas Schreiner, Sara Vandewalle, Kaatje Toye, Bruno Lapauw, (unknown), Guy T’Sjoen	114
9	Comparison of basic features of proton and helium ion pencil beams in water using GATE 2012 ·Zeitschrift für Medizinische Physik ·(unknown), Thomas Schreiner, H. Fuchs, Dietmar Georg	22
10	Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study 2011 ·Endocrine ·(unknown), Stense Farholt, (unknown), Jens Bollerslev, Thomas Schreiner, Anne Grethe Jurik, Jens Sandahl Christiansen, Charlotte Höybye	38
11	One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition: Results from a Randomized, Placebo-Controlled Study 2010 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Stense Farholt, (unknown), Jens Bollerslev, Thomas Schreiner, Anne Grethe Jurik, Jens Sandahl Christiansen, Charlotte Höybye	43
12	Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Thor Ueland, Stine Lyngvi Fougner, Kristin Godang, Tove Lekva, Leon J. Schurgers, Hanne Scholz, Bente Halvorsen, Thomas Schreiner, Pål Aukrust, Jens Bollerslev	34
13	Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial 2008 ·The Journal of Clinical Endocrinology & Metabolism ·Sven Magnus Carlsen, Morten Lund‐Johansen, Thomas Schreiner, Sylvi Aanderud, (unknown), Johan Svartberg, John G. Cooper, John Hald, Stine Lyngvi Fougner, Jens Bollerslev	152
14	Immediate Drug Release from Solid Oral Dosage Forms 2004 ·Journal of Pharmaceutical Sciences ·Thomas Schreiner, Ulrich F. Schaefer, (unknown)	22
15	Ikke-hormonproduserende hypofyseadenomer 2003 ·Tidsskrift for Den Norske Laegeforening ·Morten Lund‐Johansen, Sylvi Aanderud, Thomas Schreiner, Jens Bollerslev, S. J. Bakke, (unknown), Sven Magnus Carlsen, Johan Cappelen, Johan Svartberg	1
16	First experience with a ready-for-use rheohemapheresis system 2001 ·Transfusion and Apheresis Science ·Thomas Schreiner, (unknown), Richard Brunner, H. Borberg	2
17	Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT) 2000 ·European Journal of Endocrinology ·Trine Bjøro, Jostein Holmen, Øystein Krüger, Kristian Midthjell, (unknown), Thomas Schreiner, (unknown), (unknown)	369
18	Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children 1999 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), Klaus Schwarz, Thomas Schreiner, Markus Wiesneth, Klaus‐Michael Debatin, W Friedrich	35
19	Collection of allogeneic peripheral blood progenitor cells by two protocols on an apheresis system 1998 ·Transfusion ·Thomas Schreiner, Markus Wiesneth, (unknown), (unknown), (unknown), (unknown), Elke Erne, (unknown), (unknown)	29
20	Mobilization and Collection of Allogeneic and Autologous Peripheral Blood Progenitor Cells for Transplantation 1995 ·Transfusion Medicine and Hemotherapy ·Markus Wiesneth, Thomas Schreiner, N. Frickhofen, W Friedrich, Susanna Müller, B. Kubanek	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact